Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
1 x
$
30.00
View Cart
Checkout
Home
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
“Paliperidone Double-blind, Placebo- and Active-Controlled, Study” has been added to your cart.
View cart
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
$
30.00
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 2 Articles
Tags:
adas-cognitive-subsection-adas-cog
,
alzheimers-disease
,
alzheimers-disease-assessment-scale-adas
,
cognitive-dysfunction
,
consortium-to-establish-a-registry-for-alzheimers-disease-cerad
,
huixing-yuan
,
k-ranga-rama-krishnan
,
keith-m-gregg
,
matthias-c-kurth
,
medworks-media
,
mini-mental-status-exam-mmse
,
psychopharmacology-bulletin
,
thomas-e-gillen
Description
Description
Thomas E. Gillen, MD, MS
GENERAL PSYCHOPHARMACOLOGY
Clinical Trials in Alzheimer’s Disease
Thomas E. Gillen,MD, MS, Keith M. Gregg, PhD, Huixing Yuan, PhD, Matthias C. Kurth, MD, PhD, and K. Ranga Krishnan, MB, ChB
Related products
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Page load link
Go to Top
